Takayasu arteritis is an understudied disease but a recent article emphasizes the heavy burden it imposes on patients. New assessments devised to improve disease understanding are based on physicians' concepts of disease severity. However, wide differences exist between patient and physician priorities and more work is now needed to improve patient quality-of-life.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Yilmaz, N. et al. Impaired quality of life, disability and mental health in Takayasu's arteritis. Rheumatology (Oxford) http://dx.doi.org/10.1093/rheumatology/ket238.
Mukhtya, C. et al. EULAR recommendations for the management of large vessel vasculitis. Ann. Rheum. Dis. 68, 318–323 (2009).
Misra, R. N. et al. Development and initial validation of the Indian Takayasu Clinical Activity Score (ITAS2010). Rheumatology (Oxford) http://dx.doi.org/10.1093/rheumatology/ket128.
Sinha, D., Mondal, S., Nag, A. & Ghosh, A. Development of colour Doppler ultrasound scoring system in patients of Takayasu's arteritis and its correlation with clinical activity score (ITAS 2010). Rheumatology (Oxford) http://dx.doi.org/10.1093/rheumatology/ket289.
Merkel, P. A. et al. The OMERACT core set of outcome measures for use in clinical trials of ANCA-associated vasculitis. J. Rheumatol. 38, 1480–1486 (2011).
Walsh, M et al. Health related quality of life in patients with newly diagnosed anti-neutrophil cytoplasm antibody associated vasculitis. Arthritis Care Res. 63, 1055–1061 (2011).
Paterson, C. Measuring outcome in primary care: a patient-generated measure, MYMOP, compared to the SF-36 health survey. BMJ 312, 1016–1020 (1996).
Herlyn, K. et al. Patient-reported outcome assessment in vasculitis may provide important data and a unique perspective. Arthritis Care Res. 62, 1639–1645 (2010).
Sanderson, T. et al. The impact triad (severity, importance and self-management) as a method of enhancing the measurement of the personal life impact of rheumatic diseases (Editorial). J. Rheumatol. 38, 191–194 (2011).
Williamson, P. R. et al. Developing core outcome sets for clinical trials: issues to consider. Trials 13, 132–140 (2012).
Acknowledgements
The authors would like to thank S. Hewlett for comments on the manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
PowerPoint slides
Rights and permissions
About this article
Cite this article
Bacon, P., Sanderson, T. Vasculitis assessments—what do patients think?. Nat Rev Rheumatol 9, 641–642 (2013). https://doi.org/10.1038/nrrheum.2013.150
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrrheum.2013.150
